Literature DB >> 17245725

Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.

Inmaculada Castillo1, Elena Rodríguez-Iñigo, Juan Manuel López-Alcorocho, Javier Bartolomé, Margarita Pardo, Vicente Carreño.   

Abstract

Occult hepatitis B virus (HBV) and occult hepatitis C virus (HCV) infection are two recently described different forms of HBV and HCV infections. This work compares the clinical, virologic, and histologic characteristics of patients with occult dual infection to those of patients with single occult HBV or HCV infection. Seventy-six patients with abnormal liver function tests of unknown etiology (serum HBsAg, anti-HCV, HBV-DNA, and HCV-RNA negative) were included in the study. Viral genomes were tested in liver by real-time PCR and confirmed by in situ hybridization. Of the 76 patients, 17 had occult HBV infection (intrahepatic HBV-DNA positive, HCV-RNA negative), 35 had occult HCV infection (intrahepatic HCV-RNA positive, HBV-DNA negative) and 24 occult dual infection (intrahepatic HCV-RNA and HBV-DNA). No differences among the three groups were found regarding clinical and epidemiologic data. The median load of intrahepatic genomic and antigenomic HCV-RNA strands was similar between single occult HCV infection and occult HBV and HCV dual infection. The percentage of HCV-infected hepatocytes did not differ between these groups. In occult single HBV infection, intrahepatic levels of HBV-DNA and percentage of HBV-infected hepatocytes were similar to the group of patients with occult dual infection. Finally, no differences were found in histological liver damage among the three groups. In conclusion, liver disease in patients with occult dual infection was not more severe than in patients with single occult HBV or occult HCV infection. Moreover, in occult dual infection there is no a reciprocal inhibition of the viral genomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245725     DOI: 10.1002/jmv.20784

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  Seropositivity of hepatitis B virus and hepatitis C virus dual infection among blood donors in Nyala teaching hospital.

Authors:  Mustafa Abdalla Ali Abou; Yassir Mohammed Eltahir
Journal:  Virol J       Date:  2009-12-22       Impact factor: 4.099

Review 2.  Management of occult hepatitis B virus infection: an update for the clinician.

Authors:  José Luis Lledó; Conrado Fernández; María Luisa Gutiérrez; Sara Ocaña
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

3.  Occult hepatitis C virus infection revisited with ultrasensitive real-time PCR assay.

Authors:  Philippe Halfon; Marc Bourlière; Denis Ouzan; Damien Sène; David Saadoun; Hacène Khiri; Guillaume Pénaranda; Agnes Martineau; Valérie Oulès; Patrice Cacoub
Journal:  J Clin Microbiol       Date:  2008-04-30       Impact factor: 5.948

4.  Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?

Authors:  Emilia Zicca; Angela Quirino; Nadia Marascio; Stefania Nucara; Fernanda Fabiani; Francesco Trapasso; Nicola Perrotti; Alessio Strazzulla; Carlo Torti; Maria Carla Liberto; Alfredo Focà
Journal:  BMC Infect Dis       Date:  2014-09-05       Impact factor: 3.090

5.  Occult Hepatitis B Virus Infection and Associated Genotypes among HBsAg-negative Subjects in Burkina Faso.

Authors:  Birama Diarra; Albert Théophane Yonli; Pegdwendé Abel Sorgho; Tegwindé Rebeca Compaore; Abdoul Karim Ouattara; Wendpagnangdé Arsène Zongo; Issoufou Tao; Lassina Traore; Serge Théophile Soubeiga; Florencia Wendkuuni Djigma; Dorcas Obiri-Yeboah; Bolni-Marius Nagalo; Virginio Pietra; Rokia Sanogo; Jacques Simpore
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-01-01       Impact factor: 2.576

Review 6.  Viral Biomarkers in Chronic HBeAg Negative HBV Infection.

Authors:  Emilia Hadziyannis; Andreas Laras
Journal:  Genes (Basel)       Date:  2018-09-27       Impact factor: 4.096

7.  Occult Hepatitis B Virus Infection and Its Risks of Cryptic Transmission in Southern Ethiopia.

Authors:  Gizachew Beykaso; Andargachew Mulu; Mirutse Giday; Nega Berhe; Markos Selamu; Dawit Hailu; Tilahun Teklehaymanot
Journal:  Infect Drug Resist       Date:  2022-02-24       Impact factor: 4.003

8.  Prevalence of occult hepatitis C virus in egyptian patients with chronic lymphoproliferative disorders.

Authors:  Samar Samir Youssef; Aml S Nasr; Taher El Zanaty; Rasha Sayed El Rawi; Mervat M Mattar
Journal:  Hepat Res Treat       Date:  2012-12-12

9.  Characterization of the occult hepatitis B virus variants circulating among the blood donors from eastern India.

Authors:  Avik Biswas; Rajesh Panigrahi; Partha Kumar Chandra; Arup Banerjee; Sibnarayan Datta; Manisha Pal; Subhashish Chakraborty; Prasun Bhattacharya; Sekhar Chakrabarti; Runu Chakravarty
Journal:  ScientificWorldJournal       Date:  2013-11-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.